menu
    • menu

    Company profile for Verona Pharma

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Verona Pharma plc is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for the treatment of respiratory diseases with significant unmet medical needs. Our proprietary lead candidate, RPL554, is paving the way for a new generation of drugs, with a novel mode of action, and has the potential to provide relief for the many patients suffering from respiratory con...
    Verona Pharma plc is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for the treatment of respiratory diseases with significant unmet medical needs. Our proprietary lead candidate, RPL554, is paving the way for a new generation of drugs, with a novel mode of action, and has the potential to provide relief for the many patients suffering from respiratory conditions such as chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF) and possibly asthma.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Verona Pharmaunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    3 More London Riverside, London SE1 2RE
    Telephone
    Telephone
    +44 (0)203 283 4200
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.veronapharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Merck Completes Acquisition Of Verona Pharma
    Merck Completes Acquisition Of Verona Pharma

    07 Oct 2025

    // PRESS RELEASE

    https://www.merck.com/news/merck-completes-acquisition-of-verona-pharma/

    PRESS RELEASE
    07 Oct 2025
    Share Share
    Verona Pharma to Present Phase 3 COPD Study Analyses at ERS
    Verona Pharma to Present Phase 3 COPD Study Analyses at ERS

    16 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/16/3150586/0/en/Verona-Pharma-to-Present-Additional-Analyses-of-the-Phase-3-ENHANCE-Studies-in-COPD-at-ERS-International-Congress-2025.html

    GLOBENEWSWIRE
    16 Sep 2025
    Share Share
    Merck Had No Other Competition in Its $10 B Buyout of Verona
    Merck Had No Other Competition in Its $10 B Buyout of Verona

    07 Aug 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/its-10b-buyout-verona-merck-was-lone-ranger

    FIERCE PHARMA
    07 Aug 2025
    Share Share
    Merck Nears $10 Billion Deal for Respiratory Drugmaker Verona
    Merck Nears $10 Billion Deal for Respiratory Drugmaker Verona

    10 Jul 2025

    // PRESS RELEASE

    https://www.merck.com/news/merck-to-acquire-verona-pharma-expanding-its-portfolio-to-include-ohtuvayre-ensifentrine-a-first-in-class-copd-maintenance-treatment-for-adults-and-expected-to-drive-growth-into-the-next-dec/

    PRESS RELEASE
    10 Jul 2025
    Share Share
    Verona Pharma to Attend June 2025 Investor Conference
    Verona Pharma to Attend June 2025 Investor Conference

    21 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/21/3085542/0/en/Verona-Pharma-Announces-June-2025-Investor-Conference-Participation.html

    GLOBENEWSWIRE
    21 May 2025
    Share Share
    Verona Pharma to Present 7 Analyses of Phase 3 Studies of COPD
    Verona Pharma to Present 7 Analyses of Phase 3 Studies of COPD

    06 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/06/3074811/0/en/Verona-Pharma-to-Present-Seven-Analyses-of-the-Phase-3-ENHANCE-Studies-in-COPD-at-ATS-2025.html

    GLOBENEWSWIRE
    06 May 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search